Retrospektive NIS-Studie zur HER-2-Expression beim Urothelkarzinom

Translated title of the contribution: Retrospective NIS study on the HER-2 expression in urothelial cancer. Treatment results from the routine in patients with advanced or metastatic urothelial cancer based on the HER-2 expression -ENHANCE (hEr2 iN urotHelial cANCEr) - AB 87/23 of the Urologic Oncology Working Group (AUO)

Heidrun Rexer*, Axel S. Merseburger, Carsten Henning Ohlmann

*Corresponding author for this work
Translated title of the contributionRetrospective NIS study on the HER-2 expression in urothelial cancer. Treatment results from the routine in patients with advanced or metastatic urothelial cancer based on the HER-2 expression -ENHANCE (hEr2 iN urotHelial cANCEr) - AB 87/23 of the Urologic Oncology Working Group (AUO)
Original languageGerman
JournalAktuelle Urologie
Volume55
Issue number1
Pages (from-to)22-23
Number of pages2
ISSN0001-7868
DOIs
Publication statusPublished - 08.02.2024

Research Areas and Centers

  • Research Area: Luebeck Integrated Oncology Network (LION)

DFG Research Classification Scheme

  • 2.22-14 Hematology, Oncology
  • 2.22-23 Reproductive Medicine, Urology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  • SDG 3 - Good Health and Well-being

Access to Document

Other files and links

Cite this